CD70 - CART

Sumanta K Pal1, Ben Tran2, John B A G Haanen3,4,5

  • 1Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, California.

Cancer discovery
|April 7, 2024
PubMed
概括

化学抗原受体 (CAR) T细胞疗法对清细胞细胞癌 (ccRCC) 显示出前景. 一种针对CD70的CAR T细胞产品CTX130在I期试验中证明了安全性和有效性,实现了持久的反应.